Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TFEB: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
A protein referenced in 2 knowledge graph relationships. Key connections: promotes lysosomal_biogenesis (mechanism); semaglutide (drug) activates.
| Gene Symbol | TFEB |
| Aliases | Transcription Factor EB |
| Protein Type | Transcription Factor |
| Target Class | Protein |
| Function | TFEB is constitutively expressed in most cell types, with highest expression in tissues with high lysosomal activity including: |
| Mechanism of Action | Prioritized from 1 SciDEX hypotheses, including: The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction |
| Primary Expression | most cell types, with highest expression in tissues with high lysosomal activity including: |
| Druggability | Medium (0.50) |
| Clinical Stage | Phase II |
| Molecular Weight | 53 kDa |
| Pathways | mTOR |
| GeneCards | TFEB |
| Human Protein Atlas | TFEB |
| Enhanced brain penetration | Improved BBB crossing (B/P ratio >1.0) vs first-generation compounds (B/P <0.1) |
| Oral bioavailability | Excellent oral PK enables once-daily dosing potential |
| Associated Diseases | ALS, Alzheimer, Alzheimer's disease, Amyotrophic Lateral Sclerosis, Ataxia |
| Known Drugs/Compounds | RAPAMYCIN, TREHALOSE, trehalose, hederagenin, QGJZF, bortezomib |
| Interactions | NBR1, MTOR, AMBRA1, ATF6, HSPA5, SQSTM1 |
| SciDEX Target | View Target Profile |
| SciDEX Hypotheses | Cell-Type Specific TFEB Modulation The Mitochondrial-Lysosomal Metabolic Coupling Dys TFEB-PGC1α Mitochondrial-Lysosomal Decoupling (+1 more) |
| KG Connections | 2811 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
TFEB["TFEB<br/>(Master Regulator)"]
subgraph Activators["TFEB Activators"]
TRIM27["TRIM27<br/>(E3 Ligase)"]
CREB1["CREB1<br/>(Transcription Factor)"]
trehalose["Trehalose<br/>(Metabolite)"]
QGJZF["QGJZF"]
end
subgraph Regulators["Upstream Regulators"]
MTORC1["mTORC1<br/>(Kinase Complex)"]
AMBRA1["AMBRA1<br/>(Autophagy Regulator)"]
end
subgraph TargetGenes["Target Genes/Proteins"]
LC3["LC3<br/>(Autophagy Marker)"]
RRAG["RRAG<br/>(Lysosomal Positioning)"]
BECN1["BECN1<br/>(Autophagy Initiator)"]
end
subgraph Pathways["Regulated Pathways"]
autophagy["Autophagy"]
endocytosis["Endocytosis"]
lysosomal_biogenesis["Lysosomal Biogenesis"]
autophagic_pathway["Autophagy-Lysosomal Pathway"]
end
subgraph Outcomes["Physiological Outcomes"]
neurodegen["Neurodegenerative Disease<br/>Modulation"]
alzheimers["Alzheimer's Disease<br/>Treatment"]
end
TRIM27 -->|"activates"| TFEB
CREB1 -->|"activates"| TFEB
trehalose -->|"activates"| TFEB
QGJZF -->|"activates"| TFEB
MTORC1 -->|"regulates"| TFEB
AMBRA1 -->|"inhibits"| TFEB
TFEB -->|"regulates"| LC3
TFEB -->|"regulates"| RRAG
TFEB -->|"activates"| BECN1
TFEB -->|"activates"| autophagy
TFEB -->|"promotes"| endocytosis
TFEB -->|"regulates"| lysosomal_biogenesis
TFEB -->|"activates"| autophagic_pathway
autophagy -->|"linked to"| neurodegen
autophagic_pathway -->|"related to"| alzheimers
TFEB -->|"modulates"| neurodegen
TFEB -->|"treats"| alzheimers
classDef mainProtein fill:#ff6b6b,stroke:#c92a2a,stroke-width:3px,color:#e0e0e0,font-weight:bold
classDef protein fill:#4ecdc4,stroke:#1a9b8e,stroke-width:2px,color:#e0e0e0
classDef pathway fill:#95e1d3,stroke:#38ada9,stroke-width:2px,color:#e0e0e0
classDef outcome fill:#ffd93d,stroke:#f39c12,stroke-width:2px,color:#e0e0e0
classDef regulator fill:#a8dadc,stroke:#457b9d,stroke-width:2px,color:#e0e0e0
class TFEB mainProtein
class TRIM27,CREB1,LC3,RRAG,BECN1,QGJZF,trehalose,MTORC1,AMBRA1 protein
class autophagy,endocytosis,lysosomal_biogenesis,autophagic_pathway pathway
class neurodegen,alzheimers outcome
class Activators,Regulators regulator| Target | Relation | Type | Str |
|---|---|---|---|
| GENES | activates | gene | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| Als | activates | disease | 1.00 |
| Als | regulates | disease | 1.00 |
| AUTOPHAGY | activates | gene | 1.00 |
| syncytiotrophoblast differentiation | regulates | process | 0.95 |
| lysosome biogenesis | promotes | process | 0.95 |
| syncytiotrophoblast formation | promotes | process | 0.95 |
| lysosomal function | activates | process | 0.95 |
| lysosomal pool regeneration | regulates | process | 0.95 |
| FAM134B | upregulates | gene | 0.95 |
| MAFLD | regulates | disease | 0.95 |
| Tumor | activates | disease | 0.95 |
| Endocytosis | upregulates | process | 0.95 |
| mitochondrial function | activates | process | 0.95 |
| AUTOPHAGY | regulates | pathway | 0.94 |
| diabetic encephalopathy | therapeutic_target | disease | 0.93 |
| NLRP3 | promotes | protein | 0.92 |
| renal tumorigenesis | promotes | process | 0.92 |
| intestinal permeability | modulates | phenotype | 0.92 |
| Autophagosome and Lysosome Biogenesis | upregulates | pathway | 0.92 |
| autophagy | activates | pathway | 0.90 |
| LC3 | regulates | protein | 0.90 |
| endocytosis | associated_with | pathway | 0.90 |
| PPARGC1A | activates | gene | 0.90 |
| Lysosomal Biogenesis | regulates | process | 0.90 |
| Autophagy-Lysosomal Pathway | mediates | pathway | 0.90 |
| Lysosome Biogenesis | associated_with | process | 0.90 |
| Lysosome Biogenesis | activates | process | 0.90 |
| trophoblast differentiation | promotes | process | 0.90 |
| breast cancer | therapeutic_target | disease | 0.90 |
| SYNA | binds_to | gene | 0.90 |
| SYNB | binds_to | gene | 0.90 |
| placental hormone secretion | regulates | process | 0.90 |
| 17β-Estradiol production | modulates | process | 0.90 |
| tauopathy | therapeutic_target | disease | 0.90 |
| microglia activation | inhibits | process | 0.90 |
| lysosomal homeostasis | regulates | process | 0.90 |
| NLRP3 inflammasome | inhibits | protein | 0.90 |
| lysosomal genes | upregulates | pathway | 0.90 |
| metabolic dysfunction-associated steatohepatitis | protects_against | disease | 0.90 |
| Lysosomal Activity | upregulates | process | 0.90 |
| NFE2L2 | regulates | gene | 0.90 |
| Amyloid-Beta Clearance | activates | process | 0.90 |
| Lysosomal Transcripts | upregulates | biomarker | 0.90 |
| autophagy gene activation | mediates | process | 0.90 |
| mitophagy | promotes | process | 0.90 |
| CYP19A1 | binds_to | gene | 0.90 |
| Autophagy | mediates | process | 0.90 |
| autophagy pathway | participates_in | pathway | 0.90 |
| Source | Relation | Type | Str |
|---|---|---|---|
| cGAS-STING | activates | pathway | 0.95 |
| mTORC1 | upstream_of | protein | 0.95 |
| Urolithin A | activates | drug | 0.95 |
| Rag-GTPases | inhibits | protein | 0.95 |
| TMX2 | promotes_nuclear_import_of | protein | 0.95 |
| FLCN | inhibits | protein | 0.95 |
| Sulforaphane | activates | compound | 0.95 |
| Treahalose | activates | compound | 0.95 |
| TREHALOSE | activates | gene | 0.95 |
| TRPML1 | activates | protein | 0.95 |
| mTOR | phosphorylates | protein | 0.95 |
| RAPAMYCIN | activates | drug | 0.95 |
| TRIP12 | ubiquitinates | protein | 0.93 |
| TRIM27 | activates | protein | 0.90 |
| CREB1 | activates | protein | 0.90 |
| ROCK1 | phosphorylates | gene | 0.90 |
| Trehalose | activates | compound | 0.90 |
| Qigui Jiangzhi Formula | upregulates | drug | 0.90 |
| TMX2 | modulates | protein | 0.90 |
| mTOR inhibition | activates | process | 0.90 |
| Tnea Therapy | activates | drug | 0.90 |
| tetrandrine | modulates | compound | 0.90 |
| Mc3R Agonists | activates | drug | 0.90 |
| PPP3 | phosphorylates | gene | 0.90 |
| MTORC1 | inhibits | gene | 0.90 |
| PRKAA | activates | gene | 0.90 |
| rapamycin | targets | drug | 0.90 |
| IRISIN | activates | protein | 0.90 |
| h-e5a1c16b | targets_gene | hypothesis | 0.90 |
| h-e3e8407c | targets_gene | hypothesis | 0.90 |
| h-b9acf0c9 | targets_gene | hypothesis | 0.90 |
| h-1775578a | targets_gene | hypothesis | 0.90 |
| GABARAP | inhibits | protein | 0.88 |
| TSC2 | regulates | gene | 0.85 |
| Acetylation | modulates | mechanism | 0.85 |
| STAT3 | inhibits | entity | 0.85 |
| Lysosomal-Mediated Activation | regulates | mechanism | 0.85 |
| mTORC1 | phosphorylates | protein | 0.85 |
| nutrient insufficiency | modulates | process | 0.85 |
| MTOR | modulates | protein | 0.85 |
| 1433 | binds_to | protein | 0.85 |
| PPP2 | phosphorylates | protein | 0.85 |
| ACSS2 | binds | protein | 0.85 |
| TAL1 | regulates | enzyme | 0.85 |
| HESPERIDIN | activates | compound | 0.85 |
| ELTROMBOPAG | inhibits | drug | 0.85 |
| TFEB phosphorylation | regulates | mechanism | 0.85 |
| MC3R | modulates | protein | 0.85 |
| AMBRA1 | inhibits | protein | 0.80 |
| QGJZF | activates | drug | 0.80 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-11 | 0 hypotheses
molecular biology | 2026-04-11 | 0 hypotheses
molecular biology | 2026-04-10 | 0 hypotheses
neurodegeneration | 2026-04-08 | 0 hypotheses
neurodegeneration | 2026-04-07 | 0 hypotheses
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Autophagy and ALS: mechanistic insights and therapeutic implications. [PMID:34057020] | Chua JP, De Calbiac H, Kabashi E, Barmad | Autophagy | 2022 | 2 |
| Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of [PMID:30335591] | Rusmini P, Cortese K, Crippa V, Cristofa | Autophagy | 2019 | 2 |
| Acetylation in the regulation of autophagy. [PMID:35435793] | Xu Y, Wan W | Autophagy | 2023 | 1 |
| Mammalian lipophagy: process and function. [PMID:41681129] | Zhao R, Dai E, Kang R, Liu J, Klionsky D | Autophagy | 2026 | 0 |
| Electroacupuncture regulates neuronal ferroptosis and ferritinophagy through lys [PMID:41272418] | Tang B, Xu X, Zhao W, Zhou Q, Du G et al | J Cereb Blood Flow Metab | 2026 | 0 |
| Endothelial Transcription Factor EB Protects Against Doxorubicin-Induced Endothe [PMID:41410033] | Du W, Ringer M, Desai D, Khandakar GI, T | Circulation | 2026 | 0 |
| Proteotoxic stress triggers TFEB- and TFE3-mediated autophagy and lysosomal biog [PMID:41450115] | Zhu Z, Yang J, Montefusco S, Xia S, Ou J | Autophagy | 2026 | 0 |
| Microglia TFEB activation attenuates Alzheimer's disease pathology by enhancing [PMID:41673711] | Kim Y, Ha TY, Kondaurova O, Lee MS, Chan | J Neuroinflammation | 2026 | 0 |
| TFE3-Rearranged and TFEB-Altered Renal Cell Carcinomas: Molecular Landscape and [PMID:41899560] | Portu M, Balsa M, Cotaina M, Anguera G, | Cancers (Basel) | 2026 | 0 |
| Transcription Factor EB Drives Thrombospondin-1 Expression to Dampen Focal-adhes [PMID:41935359] | Liu C, Zhang Q, Zhou D, Li B, Cheng J et | Curr Gene Ther | 2026 | 0 |
| Modulation of the AMPK/TFEB Axis by Ezetimibe Attenuates Neuroinflammatory, Oxid [PMID:41944914] | Aditi, Wani SN, Akanksha, Kumar A, Singh | Journal of neuroimmune pharmac | 2026 | 0 |
| TFEB has a protective effect in cisplatin induced AKI through regulating exosome [PMID:41946126] | Xu Z, Xiang H, Liu H, Zhang C, Zhang X e | Int Immunopharmacol | 2026 | 0 |
| Cabozantinib activates TFEB-mediated autophagy to exert anti-tumor effects in he [PMID:41951909] | Chen C, Hu Y, Zhang C, Zhou X | In Vitro Cell Dev Biol Anim | 2026 | 0 |
| NIBV Induces Incomplete Autophagy via AMPK-TFEB, Causing Kidney Injury in Chicks [PMID:41955488] | Huang C, Zeng Y, Chen Y, Li Z, Omar SM e | Adv Sci (Weinh) | 2026 | 0 |
| Lysosomal homeostasis at the crossroads of neurodegeneration. [PMID:41919495] | De Tito S, Tooze SA | The Journal of clinical invest | 2026 | 0 |
| Targeting microglial inflammation in Parkinson's disease: irisin activates PAFAH [PMID:41520051] | Cai L, Liu Y, Tang S, Deng S, Zhang L, W | Communications biology | 2026 | 0 |
| Organelle dysfunction and TNT-mediated aggregate spreading in neurodegeneration. [PMID:41543365] | Thomas V, Zurzolo C | Physiology (Bethesda, Md.) | 2026 | 0 |
| PSAT1 inhibits mTORC1 activation by preventing Rag heterodimer formation in lung [PMID:40702660] | Liu Y, Cheng Z, Zhang J, Zhang Y, Zhao T | Autophagy | 2026 | 0 |
| Nanocarrier-enhanced simvastatin modulates AMPK-ULK1 pathway and oxidative stres [PMID:41314452] | Afify AM, El-Sayed EK, Ismail A, Nofal S | Eur J Pharmacol | 2026 | 0 |
| Macrophage PD-1 regulates energy expenditure and metabolic dysfunction under imm [PMID:41380676] | Wu MM, Yang YC, Hu ZQ, Chang JY, Xiao H | Cell Metab | 2026 | 0 |